This inventor holds 3 USPTO granted patents and 14 published patent applications, plus 7 CIPO patents and 6 EPO patents. Top assignee: Kolon Tissuegene, Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Kwan Hee Lee: Innovator in Cell Therapy
Introduction
Kwan Hee Lee is a notable inventor based in Rockville, MD, who has made significant contributions to the field of cell therapy. With a total of two patents to his name, he has focused on innovative methods for treating nerve damage and enhancing cell proliferation.
Latest Patents
Kwan Hee Lee's latest patents include a composition for primed cell therapy, which involves primed connective tissue cells combined with a pharmaceutically acceptable carrier. Additionally, he has developed a method for treating damaged nerves using a phosphatase and tensin homolog (PTEN) lipid phosphatase inhibiting peptide, which promotes the growth and proliferation of nerve cells.
Career Highlights
Throughout his career, Kwan Hee Lee has worked with prominent companies in the biotechnology sector, including Kolon TissueGene, Inc. and TissueGene, Inc. His work has been instrumental in advancing therapeutic techniques that leverage the body's own cells for healing.
Collaborations
Kwan Hee Lee has collaborated with various professionals in his field, including his coworker Moon Jong Noh, who has contributed to his research endeavors.
Conclusion
Kwan Hee Lee's innovative work in cell therapy and his commitment to advancing medical treatments highlight his importance as an inventor in the biotechnology industry. His contributions continue to pave the way for future advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile